Loading...
ROCO
6236
Market cap22mUSD
Jul 07, Last price  
17.05TWD
1D
0.00%
Jan 2017
-21.79%
IPO
5.90%
Name

Neith Corp

Chart & Performance

D1W1MN
ROCO:6236 chart
P/E
224.89
P/S
19.65
EPS
0.08
Div Yield, %
Shrs. gr., 5y
5.64%
Rev. gr., 5y
-3.74%
Revenues
36m
-20.68%
33,531,00043,742,00031,389,00032,057,00039,903,00045,571,00036,145,000
Net income
3m
P
-17,356,000-10,834,000-5,352,000-23,688,000-40,033,000-16,884,0003,158,000
CFO
9m
P
-10,652,000-11,286,0007,465,000-26,457,000-17,644,000-27,992,0009,290,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Neith Corporation operates in diverse sectors, encompassing biotechnology, medical aesthetics, and preventive health solutions. The company provides a variety of nutritional supplements, including L-One, a liquid formula designed to support ocular well-being, and EPlus, a multi-enzyme blend. Additional nutritional offerings are marketed under the King One brand. Beyond supplements, Neith also offers genetic testing services. Its product portfolio extends to a wide array of wellness and energy-enhancing items, such as versatile mattresses (energy and dual-purpose), energy-infused masks, silicon gel necklaces, waistbands, heated energy stones, and massage tools. The company further supplies water purification systems and specialized Ganbanyoku energy stone spa beds. In the beauty segment, Neith presents a line of skincare products focused on cell regeneration and rejuvenation. Other offerings include energy-focused household items, as well as microcontrollers and their associated peripheral devices. Established in 1997, Neith Corporation was initially known as Come True Biomedical Inc. The company's headquarters are situated in Taichung, Taiwan.
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT